Here's an article about this.

Robert Kaplan is a senior scholar at the Stanford University School of Medicine and co-chair of the No on Prop 38 campaign.

One of the key arguments of the No on Prop 38 campaign cites a CalMatters investigative report, which found that the highly specific criteria leave only one institution qualified to receive funding: the California Institute for Immunology and Immunotherapy, associated with UCLA and founded by Michelson.

"When I first heard of Proposition 38, I was excited about it because it provides more money for biomedical research, which I think is necessary," Kaplan said.

Kaplan says there needs to be open competition between institutions and questions the limiting of funding to a single discipline, immunotherapy, when there is a wider array of biomedical research.

He is also concerned that the anticipated 10% of revenue generated by discoveries funded through the measure to repay the General Fund could take decades, given the uncertainty in the amounts and timing.